Imprint

Imprint

Subject to change.

This annual report is also available in German and may be obtained from the Company upon request.

Annual reports, interim reports, and further information on the Company are also available on our website: www.fmc-ag.com

Printed reports can be ordered online, by phone or in writing from Investor Relations.

Published by:
Fresenius Medical Care AG & Co. KGaA

Editorial office:
Investor Relations

Editorial deadline:
March 13, 2013

Concept and design:
hw.design gmbh

Photography:

Ellen Callaway
Magazine, Food and Dialysis

Matthias Haslauer
Magazine, Dialysis at Home and cover

Christian Lietzmann
Magazine, Review 2012

Matthias Ziegler
To our Shareholders, Management Board
Magazine, Interview with Rice Powell and Dr. Ben J. Lipps, 500.000th Dialysis Machine and cover

Andreas Pohlmann
To our Shareholders, Report of the Supervisory Board

This report contains forward-looking statements that are based on plans, projections and estimates and subject to various risks and uncertainties. Actual results could differ materially from those described in these forward-looking statements due to certain factors. The risks and uncertainties are detailed in Fresenius Medical Care AG & Co. KGaA’s reports filed with the U.S. Securities and Exchange Commission. We do not undertake any obligation to update any forward-looking statements in this report.

The title, text, and illustrations are subject to copyright. Reproduction in whole or in part requires the prior written authorization of Fresenius Medical Care AG & Co. KGaA.

Fresenius Medical Care AG & Co. KGaA
Registered seat and commercial register:
Hof an der Saale (Germany), HRB 4019

Chairman of the Supervisory Board:
Dr. Gerd Krick

General partner:
Fresenius Medical Care Management AG

Registered seat and commercial register:
Hof an der Saale (Germany), HRB 3894

Management Board:
Rice Powell (Chairman),
Michael Brosnan, Roberto Fusté,
Dr. Emanuele Gatti, Ronald Kuerbitz,
Dr. Rainer Runte, Dr. Olaf Schermeier,
Kent Wanzek

Chairman of the Supervisory Board:
Dr. Ulf M. Schneider